TABLE 1

Patient Characteristics

				SUV_mean
Patient no.	Age (y)	Pathology	Lesion localization	¹⁸F-Galacto-RGD	¹⁸F-FDG
1	55	Renal cell carcinoma	Bone	3.42	4.18
			Bone	1.10	3.39
2	66	Hemangiosarcoma	Primary, liver	1.78	3.67
3	55	Squamous cell carcinoma of head and neck	Primary	2.01	9.81
			Lymph node	2.00	7.88
			Lymph node	1.99	8.52
			Lung	0.30	3.25
4	54	Invasive ductal breast cancer	Primary, breast	3.50	5.16
			Liver	2.50	4.21
			Bone	3.08	1.29
5	70	NSCLC	Primary, lung	3.14	10.94
			Lymph node	3.20	7.25
			Lymph node	3.49	4.87
			Bone	4.66	9.82
			Bone	0.80	6.82
6	62	NSCLC	Primary, lung	2.29	7.66
			Metastasis, lung	0.30	1.74
			Cerebrum	0.63	1.96
7	71	NSCLC	Primary, lung	1.29	9.09
			Metastasis, lung	1.25	5.26
			Lymph node	1.00	2.92
			Adrenal gland	3.03	23.20
			Liver	2.02	3.76
8	62	NSCLC	Primary, lung	4.01	9.65
			Bone	5.80	10.29
			Bone	5.03	6.07
			Intestine	5.23	20.45
			Lymph node	3.15	4.02
9	64	Renal cell carcinoma	Liver	1.66	3.79
			Retroperitoneum	0.30	1.82
10	68	Carcinoid of bronchus	Primary	4.45	2.21
			Liver	6.82	4.55
			Spleen	5.95	3.75
			Lymph node	6.15	7.14
			Bone	5.42	3.21
11	73	NSCLC	Primary, lung	2.45	13.73
			Bone	2.09	10.99
			Liver	1.96	13.94
			Liver	2.21	17.43
			Liver	2.61	18.63
12	71	Adenocarcinoma of rectum	Lung	3.48	8.56
			Lymph node	1.10	5.36
13	52	NSCLC	Primary, lung	3.43	2.86
			Lymph node	3.32	2.29
			Cerebrum	1.22	3.43
14	72	NSCLC	Primary, lung	3.19	9.69
			Bone	2.48	10.29
			Adrenal gland	1.88	11.51
			Liver	2.75	11.61
			Bone	3.00	8.50
15	52	Adenocarcinoma of rectum	Liver	2.34	11.07
16	80	NSCLC	Primary, lung	2.80	7.40
			Liver	1.90	5.10
17	58	NSCLC	Primary, lung	1.49	3.74
			Lymph node	1.83	8.30
			Lymph node	1.83	8.30
18	68	NSCLC	Primary, lung	3.04	18.19
			Lymph node	1.40	4.73
			Lymph node	2.62	8.25